CardioComm Press Release

CardioComm Solutions Inc. Announces Changes in Board of Directors

VICTORIA, B.C., June 21, 2006 - CardioComm Solutions Inc. (TSX-V:CCG) ("CardioComm", the "Company"), held its Annual General Meeting on June 20, 2006 . All of the resolutions as recommended by management were passed by shareholders. As such, the Company wishes to confirm that for the ensuing year the Board of Directors shall be comprised of; Stephen Martin, James Hall, John McEwen, Brad Harlow and Jay Hayden.

Mr. Joshua Smith did not stand for re-election to the Board. The Company thanks him for his years of service and wishes him well in his future endeavors. The Company also announces the resignation of Mr. Peter Crosby, Chairman of the Board. In particular, Mr. Crosby is thanked for his years of service and selfless direction.

Upon reflection, Mr. Crosby remarked "I regret that I need to leave the Board of CardioComm because of pressure of other business. However, I have enjoyed my time working with the Company, and wish the whole team great success for the future."

The two new Directors, Mr. Brad Harlow and Mr. Jay Hayden have joined the Company's Board, effective immediately. Mr. Harlow, who will serve as Chairman, brings years of hands-on leadership with a proven track record in strategic management of medical electronic, health care and custom internet software products.

Mr. Harlow is Managing Partner, B. Harlow & Associates LLC., where he consults for high profile health care & technology companies with an emphasis on strategic marketing, finance and business development. Mr. Harlow brings specific expertise with a focus on cardiology, business-to-physician services and Class II and III products. Mr. Harlow has been instrumental in guiding over $200 Million of client transactions including acquisitions, technology transfers, licenses and direct investments. Retainer based clients are located in United States , Europe and Israel .

Mr. Hayden is a partner in the Gowlings Business Law Group in Vancouver , B.C. His practice is focused on commercial and corporate transactions including share and asset purchase and sale transactions, financing transactions and acts for start-up software and medical technology companies.

Stephen Martin, President and CEO said "I have enjoyed working with Joshua and Peter over the years. Their contributions were always valuable and much appreciated, they will be missed. I am, however, delighted that Brad and Jay have agreed to serve on the Board. Each has much to contribute most notably in the development and commercialization of cardiac software and high level commercial transactions. I am looking forward to their guidance and input".

About CardioComm Solutions Inc.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMST) and GlobalCardioT. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification

On behalf of the Board of Directors of CardioComm Solutions Inc.

“Stephen Martin”

Stephen R. Martin, President & CEO

For investor information, please contact:

Stephen Martin
1-877-744-1122